Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cells

Verfasser / Beitragende:
[Stefan Bohr, Suraj Patel, Radovan Vasko, Keyue Shen, Arvin Iracheta-Vellve, Jungwoo Lee, Shyam Bale, Nilay Chakraborty, Michael Brines, Anthony Cerami, Francois Berthiaume, Martin Yarmush]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Molecular Medicine, 93/2(2015-02-01), 199-210
Format:
Artikel (online)
ID: 605543895
LEADER caa a22 4500
001 605543895
003 CHVBK
005 20210128100929.0
007 cr unu---uuuuu
008 210128e20150201xx s 000 0 eng
024 7 0 |a 10.1007/s00109-014-1218-2  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00109-014-1218-2 
245 0 0 |a Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cells  |h [Elektronische Daten]  |c [Stefan Bohr, Suraj Patel, Radovan Vasko, Keyue Shen, Arvin Iracheta-Vellve, Jungwoo Lee, Shyam Bale, Nilay Chakraborty, Michael Brines, Anthony Cerami, Francois Berthiaume, Martin Yarmush] 
520 3 |a Tissue-protective properties of erythropoietin (EPO) have let to the discovery of an alternative EPO signaling via an EPO-R/CD131 receptor complex which can now be specifically targeted through pharmaceutically designed short sequence peptides such as ARA290. However, little is still known about specific functions of alternative EPO signaling in defined cell populations. In this study, we investigated effects of signaling through EPO-R/CD131 complex on cellular stress responses and pro-inflammatory activation in different mesenchymal-derived phenotypes. We show that anti-apoptotic, anti-inflammatory effects of ARA290 and EPO coincide with the externalization of CD131 receptor component as an immediate response to cellular stress. In addition, alternative EPO signaling strongly modulated transcriptional, translational, or metabolic responses after stressor removal. Specifically, we saw that ARA290 was able to overcome a TNFα-mediated inhibition of transcription factor activation related to cell stress responses, most notably of serum response factor (SRF), heat shock transcription factor protein 1 (HSF1), and activator protein 1 (AP1). We conclude that alternative EPO signaling acts as a modulator of pro-inflammatory signaling pathways and likely plays a role in restoring tissue homeostasis. Key message: • Erythropoietin (EPO) triggers an alternative pathway via heteroreceptor EPO/CD131. • ARA290 peptide specifically binds EPO/CD131 but not the canonical EPO/EPO receptor. • Oxidative stress and inflammation promote cell surface expression of CD131. • ARA290 prevents tumor necrosis factor-mediated inhibition of stress-related genes. • Alternative EPO signaling modulates inflammation and promotes tissue homeostasis. 
540 |a Springer-Verlag Berlin Heidelberg, 2014 
690 7 |a ARA290  |2 nationallicence 
690 7 |a Oxidative stress  |2 nationallicence 
690 7 |a Heat shock  |2 nationallicence 
690 7 |a Apoptosis  |2 nationallicence 
690 7 |a TNFα  |2 nationallicence 
690 7 |a Homeostasis  |2 nationallicence 
690 7 |a Mesenchymal stem cells  |2 nationallicence 
700 1 |a Bohr  |D Stefan  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
700 1 |a Patel  |D Suraj  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
700 1 |a Vasko  |D Radovan  |u Department of Medicine, New York Medical College, Valhalla, NY, USA  |4 aut 
700 1 |a Shen  |D Keyue  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
700 1 |a Iracheta-Vellve  |D Arvin  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
700 1 |a Lee  |D Jungwoo  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
700 1 |a Bale  |D Shyam  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
700 1 |a Chakraborty  |D Nilay  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
700 1 |a Brines  |D Michael  |u Araim Pharmaceuticals, 10562, Ossining, NY, USA  |4 aut 
700 1 |a Cerami  |D Anthony  |u Araim Pharmaceuticals, 10562, Ossining, NY, USA  |4 aut 
700 1 |a Berthiaume  |D Francois  |u Department of Biomedical Engineering, Rutgers University, 599 Taylor Road, 08854, Piscataway, NJ, USA  |4 aut 
700 1 |a Yarmush  |D Martin  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
773 0 |t Journal of Molecular Medicine  |d Springer Berlin Heidelberg  |g 93/2(2015-02-01), 199-210  |x 0946-2716  |q 93:2<199  |1 2015  |2 93  |o 109 
856 4 0 |u https://doi.org/10.1007/s00109-014-1218-2  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00109-014-1218-2  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bohr  |D Stefan  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Patel  |D Suraj  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Vasko  |D Radovan  |u Department of Medicine, New York Medical College, Valhalla, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shen  |D Keyue  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Iracheta-Vellve  |D Arvin  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Lee  |D Jungwoo  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bale  |D Shyam  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chakraborty  |D Nilay  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Brines  |D Michael  |u Araim Pharmaceuticals, 10562, Ossining, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cerami  |D Anthony  |u Araim Pharmaceuticals, 10562, Ossining, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Berthiaume  |D Francois  |u Department of Biomedical Engineering, Rutgers University, 599 Taylor Road, 08854, Piscataway, NJ, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yarmush  |D Martin  |u Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children, 51 Blossom Street, 4th Floor, 02114, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Molecular Medicine  |d Springer Berlin Heidelberg  |g 93/2(2015-02-01), 199-210  |x 0946-2716  |q 93:2<199  |1 2015  |2 93  |o 109